Right Answer: E. Initiate hemodialysis
Explaination:
This patient presents with significant chronic lithium toxicity (serum lithium 3.0 mEq/L) and severe neurological symptoms (ataxia, tremors, confusion). Importantly, he also has pre-existing comorbidities (congestive heart failure) that limit aggressive intravenous (IV) fluid hydration.
The Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup provides evidence-based recommendations on when to use extracorporeal treatments like hemodialysis for various poisonings, including lithium.
According to guidelines, hemodialysis is indicated for lithium poisoning in the following scenarios:
a. Serum lithium level > 4 mEq/L, regardless of symptoms.
b. Serum lithium level > 2.5 mEq/L with pre-existing comorbidities (like CHF or volume overload) that restrict aggressive IV fluid administration, as seen in this patient.
c. Severe neurological symptoms (which this patient also exhibits).
While IV fluids (like normal saline) are generally indicated to promote renal clearance of lithium, they would not be sufficiently effective to clear such a toxic level promptly, especially since our patient has CHF which contraindicates aggressive fluid resuscitation. Mannitol and Lasix are diuretics and do not effectively enhance lithium clearance to the extent required for severe toxicity. Activated charcoal is ineffective as lithium is not significantly adsorbed. Hemodialysis offers rapid and efficient clearance of lithium (approximately 70 to 170 mL/min). A second session is often required due to lithium rebound from tissue compartments, and this rebound can be minimized if followed by continuous renal replacement therapy (CRRT). The final goal of treatment with hemodialysis is symptom resolution and a serum lithium level below 1 mEq/L.
Clinical pearls: Li toxicity
1. Narrow Therapeutic Index: Lithium's narrow therapeutic range (0.6–1.0 mEq/L) necessitates careful monitoring. Levels >1.5 mEq/L often cause toxicity, with >2.5 mEq/L potentially life-threatening. Chronic toxicity, especially in elderly or renally impaired patients, can occur even with normal therapeutic range due to accumulation.
2. Tricky Presentations: Acute and chronic toxicity manifest differently. Acute toxicity has a rapid onset and usually presents with severe GI symptoms. In contrast, chronic toxicity presents gradually with more prominent neurological signs (tremors, confusion, ataxia), sometimes at lower lithium levels.
3. Important Risk Factors: Dehydration, drug interactions (NSAIDs, ACEi/ARBs, diuretics), renal impairment, and low-sodium diets increase toxicity risk.
4. Hemodialysis Criteria**: Urgent hemodialysis is indicated for lithium levels >4.0 mEq/L (regardless of symptoms), >2.5 mEq/L with severe symptoms (seizures, coma, hemodynamic instability), >2.5 mEq/L with contraindications to IV fluids, or in cases of rebound toxicity.
5. Key Medical Management: IV normal saline is first-line for mild-moderate toxicity (if no CHF). Avoid diuretics, as they worsen dehydration without improving lithium clearance.
